Metadate CD (methylphenidate hydrochloride) Extended-Release Capsules is a central nervous system (CNS) stimulant used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy. Common side effects of Metadate CD include:

• headache,
• stomach pain,
• loss of appetite,
• weight loss,
• trouble sleeping (insomnia),
• dizziness,
• nausea,
• vomiting,
• lightheadedness,
• irritability,
• nervousness,
• blurred vision or other vision problems,
• dry mouth,
• constipation,
• sweating,
• skin rash,
• numbness/tingling/cold feeling in your hands or feet,
• blue fingers or toes, or
• (rarely) drowsiness.
• Metadate CD may raise your blood pressure. Check your blood pressure regularly and tell your doctor if the results are high.

The recommended starting dose of Metadate CD is 20 mg once daily. Dosage may be adjusted in weekly 10-20 mg increments to a maximum of 60 mg/day, depending upon tolerability and effectiveness. Metadate CD may interact with blood thinners, clonidine, dobutamine, epinephrine, isoproterenol, cold/allergy medicine that contains phenylephrine potassium citrate, sodium acetate, sodium bicarbonate, citric acid, potassium citrate, sodium citrate and citric acid, medications to treat high or low blood pressure, stimulant medications or diet pills, seizuremedicine, or antidepressants. Tell your doctor all medications you are taking. Metadate CD should be used only when prescribed during pregnancy. It is not known whether this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Metadate CD (methylphenidate hydrochloride) Extended-Release Capsules Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.